In a recent survey, the Science Advisory Board asked 500 of its U.S. members to share their views on the direct-to-consumer (DTC) testing industry, specifically in the context of the FDA's warning letter to 23andMe back in November of 2013. (You can see the results of that survey here.) What are your thoughts on the issue?
Should the FDA further extend regulations regarding DTC testing technologies?
Yes, there is a significant lack of regulation in this area
Yes, but only for a subset of these products
No, it would have a negative effect on these innovations
No, consumers should have access to as much personalized medical info as possible